About Standard
News
Products info
Research Development & Innovation
For Investors
Corporate Governance
Board of DiretorsShare Holder Meeting
Share Holder MeetingDividends
Dividends
About Standard
News
Products info
Research Development & Innovation
For Investors
Standard offers a variety of products to our International partners. Most products are in oral dosage forms — tablets and capsules. Our facilities are FDA approved and we have experience with registrations in most ASEAN countries and US. We have flexible terms and you can count on our facilities in Taiwan to meet your customer product needs.
We are continuously investing in R&D, ensuring a long future for Standard and our partners. One of our core strengths lies with our vertical integration from formulation, API development, product development, and manufacturing.
Currently, we sell to over 30 countries and we aim to be competitive in the timing of our launches for our pipeline products. Our goal is to increase our presence throughout Asia Pacific and Americas by licensing to strategic partners and supplying high quality product.
For a complete list of our products available for licensing please submit your opportunity for our consideration.